Sarah Able
Impact in
- Physiology top 10%
- Adenosine and Purinergic Signaling
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Radiopharmaceutical Chemistry and Applications 12
- Optical Imaging and Spectroscopy Techniques 1
- Co-authors
- Katherine A. Vallis (16 shared papers)Ole Tietz (3 shared papers)Rod Chalk (2 shared papers)Fernando Cortezon‐Tamarit (1 shared paper)Sidath D. KATUGAMPOLA (3 shared papers)Bart T. Cornelissen (4 shared papers)Veerle Kersemans (5 shared papers)Carolyn M. Napier (3 shared papers)
- Journals
- Journal of Nuclear Medicine (2 papers)Nature Chemistry (1 paper)Life Sciences (1 paper)European Journal of Pharmacology (1 paper)Methods in enzymology on CD-ROM/Methods in enzymology (1 paper)
- Partner nations
- United KingdomUnited StatesAustria
In The Last Decade
Sarah Able
21 papers receiving 644 citations
Peers
Comparison fields: 5 of 62
- Physiology 32
- Biomaterials 97
- Radiology, Nuclear Medicine and Imaging 154
- Drug Discovery 1
- Biomedical Engineering 130
Countries citing papers authored by Sarah Able
This map shows the geographic impact of Sarah Able's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Able with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Able more than expected).
Fields of papers citing papers by Sarah Able
This network shows the impact of papers produced by Sarah Able. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Able. The network helps show where Sarah Able may publish in the future.
Co-authors
The 25 scholars most cited alongside Sarah Able, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 130 | |
| 2 | 2012 | 78 | |
| 3 | 2012 | 68 | |
| 4 | 2018 | 67 | |
| 5 | 2010 | 44 | |
| 6 | 2021 | 38 | |
| 7 | 2018 | 30 | |
| 8 | 2017 | 22 | |
| 9 | 2013 | 21 | |
| 10 | 2021 | 21 | |
| 11 | 2021 | 20 | |
| 12 | 2016 | 17 | |
| 13 | 2021 | 17 | |
| 14 | 2020 | 16 | |
| 15 | 2009 | 14 | |
| 16 | 2014 | 13 | |
| 17 | 2019 | 13 | |
| 18 | 2017 | 11 | |
| 19 | 2009 | 10 | |
| 20 | 2016 | 5 |
About Sarah Able
Sarah Able is a scholar working on Radiology, Nuclear Medicine and Imaging, Physiology, Biomedical Engineering, Oncology and Endocrine and Autonomic Systems, having authored 21 papers that have together received 658 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (12 papers), Nanoplatforms for cancer theranostics (3 papers), Ultrasound and Hyperthermia Applications (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), RNA Interference and Gene Delivery (1 paper), Optical Imaging and Spectroscopy Techniques (1 paper), Sleep and Wakefulness Research (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). The work is most often cited by research in Physiology (32 citations), Biomaterials (97 citations), Radiology, Nuclear Medicine and Imaging (154 citations), Drug Discovery (1 citation) and Biomedical Engineering (130 citations). Sarah Able has collaborated with scholars based in United Kingdom, United States and Austria. Frequent co-authors include Katherine A. Vallis, Ole Tietz, Rod Chalk, Fernando Cortezon‐Tamarit, Sidath D. KATUGAMPOLA, Bart T. Cornelissen, Veerle Kersemans, Carolyn M. Napier, William B. Johnson and Siân E. Harding. Their work appears in journals such as Journal of Nuclear Medicine, Nature Chemistry, Life Sciences, European Journal of Pharmacology and Methods in enzymology on CD-ROM/Methods in enzymology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.